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BRIEF DEFINITIVE REPORT
        The terminal diff  erentiation of eff  ector lym-
phocytes after encounter with antigen is a com-
plex and tightly regulated process that ensures 
rapid, but limited, immune responses. Tran-
scription factors play crucial regulatory roles in 
the diff  erentiation processes that culminate in 
the formation of eff  ector and memory B and 
T cells (  1, 2  ). 
  The transcriptional repressor B lymphocyte  –
  induced maturation protein-1 (Blimp-1) is one 
of the few transcription factors known to be 
crucial for regulating B lymphocyte terminal 
diff  erentiation. Blimp-1 is required (  3  ) and suf-
fi  cient (  4  ) for the formation of fully functional 
antibody-secreting plasma cells and for main-
tenance of long-lived plasma cells in the bone 
marrow (  5  ). 
  Blimp-1 is a SET domain and a zinc fi  nger  –
  containing transcriptional repressor encoded by 
the   Prdm-1   gene. Transcriptional repression by 
Blimp-1 is mediated by repressive modifi  cations 
in chromatin structure, through recruitment of 
Groucho family transcriptional corepressors, and 
chromatin-modifying enzymes (for review see 
[  6  ]). In addition to its crucial role in the diff  er-
entiation of plasma cells, Blimp-1 has critical 
functions in embryonic development (  7, 8  ), and 
targeted deletion of the   Prdm1   gene in the mouse 
is embryonically lethal (  9  ). Blimp-1 is also required 
for terminal diff  erentiation of several nonlym-
phoid cell lineages in adult organisms (for re-
view see [  6  ]). 
  Recently, a role for Blimp-1 in T cell diff    er  en-
tiation was demonstrated in two labora  tories (  10, 
11  ). After T cell receptor (TCR) stimulation, 
both CD4  +   and CD8  +   T lymphocytes express 
Blimp-1 mRNA in amounts compara  ble to that 
in fully mature plasma cells. Blimp-1 mRNA is 
also expressed at high levels in Foxp3  +  CD4  +   reg-
ulatory T cells. Conditional deletion of Blimp-1 
in T cells results in profound alter  ations of 
T cell homeostasis and function and culmi-
nates in the spontaneous development of fatal 
colitis (  10, 11  ). Blimp-1  –  defi  cient CD4  +   regu-
latory T cells (T reg cells) are partially dysfunc-
tional, as they perform properly in in vitro 
immunosupression assays and in one colitis model 
in vivo (  11  ), but fail to inhibit chemically induced 
colitis in WT mice (  10  ). 
  TCR stimulation of Blimp-1 –  defi  cient CD4  +   
T cells in vitro results in hyperresponsiveness 
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with results from polyclonal stimulation (  10  ), TCR restimu-
lation 3 d after primary activation also resulted in more IL-2  – 
producing cells in the CKO cultures (  Fig. 1 A  ).   CKO cells 
proliferated more robustly, especially when antigen was pro-
vided in lower doses (Fig. S1 A, available at http://www.jem
.org/cgi/content/full/jem.20080526/DC1). Thus, Blimp-1 
attenuates proliferation and the number of IL-2  –  producing 
cells upon antigen-specifi  c stimulation, and attenuation of 
IL-2 production by Blimp-1 can be observed at the time of 
primary stimulation. 
  IL-2 is known to induce Blimp-1 in B cells (  4  ), and most 
of the induction of Blimp-1 mRNA and protein upon T 
cell activation has been shown to depend on IL-2 produc-
tion (  12  ). Consistent with our observation of increased IL-2 
production in Blimp-1 CKO T cells (  Fig. 1 A  ) (  10  ), forced 
expression of Blimp-1 in T cells decreases expression of IL-2 
(  12, 13 ), and IL-2 causes its own down-regulation ( 12, 19 ). Given 
these complicated interactions, we investigated the kinetics 
of Blimp-1 and IL-2 expression in normal T cells, measuring 
steady-state mRNA levels. At days 1 and 2 after stimulation 
of naive CD4  +   T cells in vitro, IL-2 steady-state mRNA is 
more strongly induced than Blimp-1 mRNA. However, by 
day 3, Blimp-1 mRNA increases signifi  cantly and IL-2 mRNA 
decreases (  Fig. 1 B  ). To study this at the single-cell level, we 
used a mouse in which Blimp-1 mRNA expression is reported 
by EGFP (  7  ). Total spleen cells were stimulated in vitro and 
analyzed for IL-2 and GFP expression. 1 d after stimulation, 
  <  10% of the CD4  +   T cells expressed GFP, whereas     5% of 
cells expressed IL-2. 3 d after stimulation, GFP expression 
increased to 17%, whereas IL-2 expression decreased to   <  3% 
(  Fig. 1 C  , top right). Restimulation on day 3 resulted in in-
creased expression of both IL-2 protein and Blimp-1 mRNA, 
and addition of IL-2 amplifi  ed Blimp-1 expression, while de-
creasing IL-2 production (  Fig. 1 C  , bottom). Strikingly, in 
all time points, very few cells were double-positive for GFP 
and Blimp-1. 
  Previous studies show that IL-2 production is tightly regu-
lated (  20, 21  ), and that even under optimal conditions not all 
T cells in a population will acquire the competence to transcribe 
the   Il2   gene and synthesize IL-2 upon primary stimulation 
(  22  ). The negative correlation between Blimp-1 expression 
and IL-2 production at the single-cell level (  Fig. 1, B and C  ), 
along with the observation that more cells make IL-2 when 
Blimp-1 is absent (  Fig. 1 A  ), provide evidence that expression 
of Blimp-1 is important in the exclusion of IL-2 production 
upon TCR stimulation. These results confi  rm and expand 
previous data (  10, 12  ), supporting the model that upon T cell 
activation, most induction of Blimp-1 occurs secondary to 
IL-2 production and that the induced Blimp-1 participates in 
a regulatory loop to repress IL-2 expression. 
  Blimp-1 is required for cytokine deprivation  –  induced cell 
death after activation 
  IL-2 also has important eff  ects on T cell apoptosis (  18  ). After 
T cell activation, IL-2 production decreases, triggering pas-
sive cell death and limiting T cell numbers at the conclusion 
that is revealed by robust proliferation in suboptimal stimu-
latory conditions and increased numbers of IL-2 producers, 
indicating that Blimp-1 is a negative regulator of IL-2 produc-
tion (  10  ). This idea is also reinforced by two recent observations: 
(a) Blimp-1 and IL-2 expression upon TCR stimulation are 
inversely correlated, and (b) enforced expression of Blimp-1 
in T cells represses IL-2 production upon TCR stimulation 
(  12, 13  ). 
  IL-2 was initially identifi  ed as an autocrine cytokine nec-
essary for in vitro expansion of T cells (  14  ). Subsequent stud-
ies indicated a role for IL-2 in promoting T cell expansion, 
survival, eff  ector diff  erentiation, and memory cell survival 
via promotion of IL-7R expression (  15  ). Indeed, the stimula-
tory properties of IL-2 make it a therapeutic target, especially 
in AIDS and cancer, where IL-2 administration promotes 
T cell expansion in vivo (  15, 16  ). IL-2 has also been shown to 
participate in the contraction of infl  ammatory responses, by 
programming activated CD4  +   T cells for apoptosis (  17, 18  ) and 
promoting the growth and survival of the innate CD4  +  FoxP3  +  T 
reg cells (  15  ). Because of these eff  ects, IL-2  –   or IL-2R  –  de-
fi  cient mice exhibit a multifaceted autoimmune pheno  type char-
acterized by multiorgan infl  ammation, absence of T reg cells, 
and accumulation of autoreactive T cells (for review see [  15  ]). 
  Interestingly, IL-2 represses its own expression in a classical 
negative-feedback loop that functions in a STAT-5  –  dependent 
manner (  19  ). This fi  nding, together with the observation that 
IL-2 is a potent inducer of Blimp-1 expression in T cells (  12  ), 
led to the suggestion that Blimp-1 plays important roles in 
IL-2 autoregulation. 
  We have investigated this hypothesis, and report that Blimp-1 
directly represses the   Il2   gene and indirectly represses   Il2   
by repressing   Fos  , which encodes Fos; Fos is a component 
of AP-1, a strong activator of   Il2  . As a consequence of the in-
creased production of IL-2 in the absence of Blimp-1, CD4  +   
T cell proliferate more upon antigen-specifi  c stimulation and 
are more resistant to cytokine deprivation  –  induced cell death. 
Attenuation of IL-2 production by Blimp-1 plays a role in 
an antigen-specific response in vivo. Thus, one important 
function of Blimp-1 in T cells is to attenuate IL-2 produc-
tion upon antigen stimulation, by both direct and indirect 
gene repression. 
    RESULTS AND DISCUSSION   
  Blimp-1 attenuates IL-2 expression in the primary response 
  We have previously reported that lack of Blimp-1 results in 
increased proliferation and IL-2 production after polyclonal 
TCR stimulation (  10  ). To further understand the mecha-
nisms by which Blimp-1 regulates IL-2 production, we eval-
uated the kinetics of IL-2 production in an antigen-specifi  c 
context. Blimp-1 conditional KO (CKO) mice were bred 
to OT2 TCR transgenic mice to generate antigen-specifi  c, 
Blimp-1  –  suffi   cient (Ctrl) and   –  defi  cient (CKO) CD4  +   T cells. 
When naive (CD44  low  ) OT2 CD4  +   cells were stimulated in 
vitro with APCs and cognate antigen, the percentage of IL-2  – 
producing cells was signifi  cantly higher in the CKO than in 
the Ctrl cultures in all time points evaluated. In agreement JEM VOL. 205, September 1, 2008  1961
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sence of Blimp-1 was responsible for the increased survival of 
eff  ector cells in this assay (  Fig. 2  ). Thus, Blimp-1  –  dependent 
repression of IL-2 is important for passive cell death at the con-
clusion of an immune response. 
  Lack of Blimp-1 results in increased IL-2 and Fos mRNA 
  We wished to understand the molecular mechanism by which 
Blimp-1 controls IL-2 production. Although the production 
of IL-2 is regulated transcriptionally and posttranscriptionally 
(  20, 21  ) because Blimp-1 is a transcriptional repressor, it prob-
ably regulates the transcription of the   Il2   gene, either directly 
and/or indirectly. To test this hypothesis, we fi  rst analyzed 
steady-state levels of IL-2 mRNA in cells from Ctrl and CKO 
mice. Naive CD4  +   cells from CKO mice had significantly 
of an immune response. Because our data (  Fig. 1  ) implicated 
Blimp-1 in postactivation down-regulation of IL-2, we next 
investigated whether Blimp-1 also plays a role in passive cell 
death after IL-2 withdrawal. 
  Naive CD4  +   T cells from Ctrl or CKO mice were stimu-
lated for 5 d, in optimal conditions, so IL-2 production was 
maximal and Blimp-1 expression was high in the Ctrl cells. 
5 d after stimulation, cells were extensively washed and re-
plated with or without exogenous IL-2. Blimp-1 CKO cells 
survived better in the absence of exogenous IL-2, and there 
were two- to threefold more live cells in CKO cultures com-
pared with Ctrl (  Fig. 2  ).   Addition of IL-2 at the time of re-
plating abrogated the diff  erences between Ctrl and CKO 
cells, indicating that the increased IL-2 production in the ab-
    Figure 1.         Expression of Blimp-1 and IL-2.   (A) Production of IL-2 by naive CD4  +   OT2  Blimp-1 – suffi  cient (Ctrl) and   –  defi  cient (CKO) cells stimulated 
with 0.1      M OVA and APC (determined as described in Materials and methods). Data shown is the percentage of IL-2  –  producing cells in the live, CD4  +   cell 
gate. (B) Steady-state Blimp-1 and IL-2 mRNA (determined by quantitative real-time PCR) in naive WT CD4  +   T cells stimulated as described in Materials 
and methods. (C) Few, if any, Blimp-1  –  expressing cells produce IL-2. Lymph node and spleen cells from Blimp-1-GFP reporter mice were stimulated (top) 
or restimulated (bottom) and stained for IL-2 and GFP. Plots show GFP and IL-2 in the CD4  +   cells.  Specifi  city of GFP staining is shown on the top left.     1962 REPRESSION OF   IL2   BY BLIMP-1   | Martins et al. 
cells compared with Ctrl cells (unpublished data). Because a 
direct correlation between Pol II binding and transcription 
has been previously demonstrated for the   Il2   gene (  26  ), this 
suggested that Blimp-1 directly represses   Il2   transcription. 
To test this hypothesis and identify Blimp-1 response elements, 
we searched the genomic sequence (plus 10 kb upstream and 
10 kb downstream of the transcriptional start site [TSS]) of 
the mouse and human   Il2   genes, looking for Blimp-1 con-
sensus binding sites (CBSs). We found 20 putative CBSs for 
Blimp-1 in the mouse   Il2   gene (Table S1, available at http://
www.jem.org/cgi/content/full/jem.20080526/DC1), and 
8 of these sites (     7,252,      5,547,      4,795,      4,765,      4,221, 
     4,207,      3,982, and      1,861) were contained in an 8.4-kb 
region upstream of the   Il2   TSS, which has been shown to 
be repressed by Blimp-1 in an in vitro reporter assay (  12  ). We 
focused our eff  orts on these sites fi  rst; however, some sites 
were embedded in simple-sequence repeats and we were un-
able to design primers for effi   cient amplifi  cation of these re-
gions. Thus, sites      3,982,      1,861, in the upstream region of 
the gene, and +10,215 and a region containing no Blimp-1 
consensus sequence (+1,556 to +1,713 bp) relative to the TSS 
were investigated. We assayed binding of endogenous Blimp-1 
by ChIP in WT CD4  +   T cells after 6-d stimulation and re-
stimulation in vitro, a condition where Blimp-1 expression is 
high (  6  ). Out of the 3 Blimp-1 CBSs investigated, only site 
     1,861 was enriched for Blimp-1 binding (  Fig. 4 A  ).   Sites 
     3,982 and +10,215, as well as the irrelevant site, showed 
no signifi  cant enrichment (  Fig. 4 A  ). Thus, Blimp-1 binds 
specifi  cally at the site      1,861 of the   Il2   gene. 
  Previous studies showed that an 8.4-kb region of the   Il2   
promoter, containing this site, conferred proper expression in 
higher amounts of steady-state IL-2 mRNA than cells from 
Ctrl mice, before and at later time points after stimulation 
(days 2 and 3), but not earlier (  Fig. 3 A  ).   This suggests that 
low levels of Blimp-1 in naive cells (  10  ) are suffi   cient to re-
press   Il2   before activation. Alternatively, or in addition, the 
repression of   Il2   by Blimp-1 in naive cells could be facilitated 
by the regulatory pathways operating before TCR stimu-
lation, which diff  er considerably from the ones in place after 
stimulation (  21  ). Upon activation of   Il2   by NFAT, members 
of AP-1 family and NF-     B (  21  ), the relatively low amounts 
of Blimp-1 are apparently overcome, and Blimp-1 cannot re-
press   Il2  . However, as Blimp-1 levels rise, Blimp-1 is once again 
able to repress   Il2   transcription. If higher levels of Blimp-1 
are, indeed, required to contain   Il2   transcription upon TCR 
stimulation, it would also explain why restimulation at day 3 
results in more   Il2   mRNA in Blimp-1 CKO cells, as in these 
circumstances Blimp-1 expression in WT cells is further elevated 
(  Fig. 1 C  ; unpublished data). Repression of   Il2   by Blimp-1 
is also consistent with the recent observation that enforced 
expression of Blimp-1 represses IL-2 production upon TCR 
stimulation (  12, 13  ). 
  Fos, a component of the AP-1 family of transcription fac-
tors, is one of the well-known transcriptional activators of the 
  Il2   gene in T cells (  23, 24  ). Because our previous studies (  25  ) 
showed that   Fos   is a direct target of Blimp-1  –  dependent re-
pression in keratinocytes, we asked if Blimp-1 repressed   Fos   
in T cells. Blimp-1  –  defi  cient CD4  +   T cells stimulated (as de-
scribed in Materials and methods) showed increased levels of 
Fos steady-state mRNA (  Fig. 3 B  ). Thus, Blimp-1 normally 
down-regulates the steady-state mRNA of both   Il2   and its 
activator   Fos  . 
  Blimp-1 directly represses the   Il2   and   Fos   genes 
  Preliminary chromatin immunoprecipitation (ChIP) experi-
ments showed increased specifi  c binding of Pol II to the tran-
scription initiation site of the   Il2   gene in activated CKO CD4 
    Figure 2.         Attenuation of IL-2 production by Blimp-1 promotes 
susceptibility to IL-2 deprivation  –  induced cell death.   Control  and 
CKO naive CD4  +   T cells were stimulated with plate-bound     CD3,     CD28, 
and IL-2 for 5 d (primary stimulation), washed, and replated in medium 
only (left) or in the presence of IL-2 (right). Cell death was determined by 
staining with Annexin V and 7-AAD. Results shown (mean and SEM from 
two independent experiments) are the percentage of Annexin V         and 
7-AAD         cells.        Figure 3.         Blimp-1 defi  ciency results in increased levels of IL-2 
and Fos steady-state mRNA.   Steady-state IL-2 (A) and Fos (B) mRNA in 
naive (day 0) and stimulated CD4  +   T cells from Control and CKO mice. 
In A, the middle graph shows steady-state IL-2 mRNA (normalized to 18 S) 
before and after restimulation. Ratios (CKO/Ctrl) from values in left graphs 
are shown in the right graphs. Results are representative of three to 
fi  ve experiments.     JEM VOL. 205, September 1, 2008  1963
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the eff  ects of Fos in regulating proliferation can only be 
  observed when both FosB and Fos are missing (for review 
see [  30  ]). 
  Lack of Blimp-1 leads to increased IL-2 production in vivo 
  Our data (  Figs. 1  –  2 and 4  ), and that of others (  12, 19  ), show 
that the transient nature of IL-2 production after T cell acti-
vation depends on induction of Blimp-1 by IL-2 and subse-
quent Blimp-1  –  dependent repression of IL-2 production via 
repression of   Il2   and   Fos  . To explore the role of Blimp-1  –  de-
pendent repression of IL-2 in vivo, we transferred Ctrl and 
CKO CFSE-labeled naive CD4  +   OT2 (CD45.2) into allotype 
congenic recipients (C57BL/6 SJ CD45.1), and then immu-
nized the recipients with dendritic cells pulsed with OVA 
peptide. 5 d later, cells were recovered from lymph nodes of 
recipients and restimulated in vitro, and IL-2 production was 
evaluated in the CD45.2  +   population by intracellular cyto-
kine staining. At this time point, both proliferation and IL-2 
production were more pronounced in the Blimp-1 CKO 
cells (  Fig. 5, A and B  ). Approximately twofold more Blimp-1 
CKO cells entered cell cycle compared with the Ctrl cells 
(  Fig. 5 A  ). In addition, in mice injected with CKO cells, 
    40% of the CD45.2  +   cells were producing IL-2, whereas 
16% of the CD45.2  +   cells were IL-2 producers in the mice 
injected with Ctrl cells (  Fig. 5 B  ). Therefore, Blimp-1 atten-
uates CD4  +   T cell proliferation and IL-2 production upon 
antigen-specifi  c TCR stimulation in vivo (  Fig. 5  ). 
transgenic cells (  27  ) and forced expression of Blimp-1 decreased 
expression of this transgene (  12  ). Although another potential 
Blimp-1 CBS is present in the 8.4-kb region (site -3,982), 
this site does not seem to bind Blimp-1 in vivo (  Fig. 5 A  ).   
Thus, the      1,862-bp site is likely to mediate repression of   Il2   
by Blimp-1, although other currently untested sites in the 8.4-kb 
regulatory region (Table S1) may also contribute. 
  We also evaluated Blimp-1 binding to previously identifi  ed 
sites in   Fos   (  25  ). Sites located at      179 and      4,990 bp from 
the TSS of mouse   Fos   are enriched for Blimp-1 binding in 
CD4  +   T lymphocytes. These results, together with previous 
results (  Figs. 1  –  3  ), demonstrate that Blimp-1 directly represses 
transcription of   Il2   and the   Il2   activator   Fos  . 
  We conclude that Blimp-1 attenuates IL-2 production 
both directly, by repression of the   Il2   gene, and indirectly, by 
repression of   Fos  . Nevertheless, the contribution of Fos to 
the overall increase in   Il2   transcription in the CKO cells is 
diffi   cult to determine. Enforced expression of Fos in T cells 
caused elevated IL-2 production (  28  ); however, deletion of 
Fos alone is insuffi   cient to decrease IL-2 production (  29  ), and 
    Figure 4.         Blimp-1 binds to the mouse       Il2   and   Fos   genes.   (A) ChIP of 
endogenous Blimp-1 bound in various regions of the   Il2   and   Fos   genes. 
WT purifi  ed CD4  +   T cells were stimulated in vitro for 6 d, restimulated 
with PMA and ionomycin for 4 h, and cross-linked for ChIP. Data repre-
sent fold enrichment of      Blimp-1 antibody over control antibody. Snail3 
is used as a negative control. NR is a region containing no Blimp-1 con-
sensus sequence. Results shown are the mean and SEM from four to fi  ve 
different experiments. (B) Representation of the   Il2   and   Fos   mouse  genes, 
with the sites shown in A marked. Sites enriched for Blimp-1 binding are 
marked with asterisks. The      4,990 site at the   Fos   gene is conserved be-
tween the human and mouse genes. No sites found at the   Il2   gene  are 
conserved between mouse and human.     
    Figure 5.         Lack of Blimp-1 results in increased proliferation and IL-2 
production in vivo.   CFSE-labeled naive Ctrl or CKO CD45.2 OT2 CD4  +  
T cells were injected i.v. into CD45.1 congenic WT mice. 2 d later, mice 
were immunized i.v. with antigen-pulsed APCs, and 5 d later, lymph nodes 
were collected and proliferation (A) and IL-2 production (B) were analyzed. 
Data in B are the mean (  ±   SEM) of the percentage of IL-2  –  producing cells 
in the CD45-2  +   gate in four different experiments. (C) Schematic repre-
sentation of Blimp-1 participation in IL-2 autoregulation. Induction/acti-
vation of N-FAT, AP-1, and NF-     B upon TCR and CD28 stimulation leads 
to IL-2 transcription. IL-2 acting via STAT-5 leads to Blimp-1 expression. 
Blimp-1 then represses the   Il2   and   Fos   genes, inhibiting IL-2 production.     1964 REPRESSION OF   IL2   BY BLIMP-1   | Martins et al. 
fraction contained   >  90% CD4  +   cells. Naive B6 OT2-TG   Prdm1    F/F   CD4-
Cre  +   or   Prdm1    +/+   CD4-Cre  +   cells were stimulated in 48-well plates at a 1:1 
ratio with APC (T cell  –  depleted and mytomycin-treated spleen cells) in a 
total of 5   ×   10  5   cells per well with chicken OVA peptide (OVA 323  –  339; 
BP10-910 H2N-ISQAVHAAHAEINEAGR-OH; New England Peptide) 
for 3 d. IL-2 production was determined after incubation with 10      g/ml 
Brefeldin A (BFA; Sigma-Aldrich) for the last 2 h of culture. When indicated, 
restimulation was done with 50 ng/ml PMA and 500 ng/ml ionomycin (both 
from Sigma-Aldrich) for 4 h, with BFA added in the last 2 h. IL-2 was de-
tected by intracellular staining in combination with surface CD4 (both anti-
bodies from BD Biosciences). Cells were analyzed in a LSRII fl  ow cytometer 
(BD Biosciences). IL-2 staining was evaluated exclusively in the live, CD4  +   
gated lymphocytes. 
  Simultaneous detection of Blimp-1 expression and IL-2 production.   
  To evaluate IL-2 expression in Blimp-1-EGFP reporter cells, total spleen cells 
were stimulated with 1      g/ml soluble      CD3 and 0.5      g/ml      CD28 (both 
from BioExpress) with or without rHuIL-2 (QIAGEN). GFP expression was 
detected in permeabilized cells using an      GFP antibody (rabbit      GFP; Rock-
land Immunochemicals, Inc.) added simultaneously with the      IL-2 antibody. 
The      GFP antibody specifi  cally stained GFP produced under the stimulation 
of the Blimp-1 transgenic promoter, as no staining was detected in nontrans-
genic cells stimulated and stained in the same way (  Fig. 1 C  ). 
  Quantitative real-time PCR.     For detection of Blimp-1, IL-2, and Fos 
mRNAs, naive CD4  +   T cells were stimulated with 5      g/ml plate-bound 
     CD3, 2.5      g/ml      g/ml      CD28, and 25 U/ml IL-2 for various time points. 
Total mRNA was isolated using TRIzol reagent (Life Technologies) accord-
ing to the manufacturer  ’  s instructions. Reverse transcription was performed 
on equal amounts of RNA for each sample using SuperScript III (Invitrogen). 
SYBR Green incorporation quantitative real-time PCR was performed using 
a FastStart SYBR Green mix (Roche) in the ABI7400 Sequence Detection 
System (Applied Biosystems). Primers used were as follows: IL-2 forward, 
5     -AGCAGCTGTTGATGGACCTA-3     ; IL-2 reverse, 5     -CGCAGAGGT-
CCAAGTTCAT-3      (designed using Primer 3 software). Primers for Blimp-1 
and Fos were previously described (  10, 25  ). 
  ChIP.     ChIP assays were performed as previously described (  25  ), with few 
modifi  cations. Cells were fi  xed with 1.1% paraformaldehyde for 10 min at 
room temperature. Sonicated chromatin from 4  –  5   ×   10  7   cells was immuno-
precipitated with 25      l of either rabbit      Blimp-1 polyclonal antibody serum 
(clone 267) or preimmune serum as a control. SYBR Green incorporation 
quantitative real-time PCR was performed in DNA recovered from immuno-
precipitation and input samples (primers sequences in Table S2, available 
at http://www.jem.org/cgi/content/full/jem.20080526/DC1). Fold enrich-
ment was calculated dividing the percentage of input values obtained with 
     Blimp by the one obtained with Ctrl antibody. Analysis of sequence homol-
ogy and identifi  cation of putative Blimp-1 consensus sites were performed 
using the ECR browser (http://ecrbrowser.dcode.org) and rVista 2.0 soft-
ware. Genomic sequences were obtained from Ensembl. 
  In vivo immunization.     CFSE-labeled naive B6 OT2-TG   Prdm1    F/F   CD4-
Cre  +   or   Prdm1    +/+   CD4-Cre  +   cells (CD45-2  +  ) (1   ×   10  6  ) were transferred (i.v.) 
to allotype-marked congenic recipients (C57Bl/6 SJ CD45.1). 2 d after cell 
transfer, mice were immunized i.v. with GMCSF-bone marrow  –  derived 
dendritic cells matured with LPS and IL-4 and pulsed with the cognate pep-
tide (1      g/ml OVA 334  –  339). 5 d later, lymph nodes were recovered and 
CFSE dilution was evaluated in the CD45.2  +   cells. Alternatively, freshly har-
vested total lymph node cell suspensions were restimulated in vitro with PMA 
and ionomycin (with BFA added in the last 2 h), and IL-2 production was 
evaluated at the single-cell level in the CD45-2  +   population by intracellular 
cytokine staining. 
  Cytokine deprivation cell death assay.     Naive CD4  +   T cells were stimu-
lated (as described in Quantitative real-time PCR) for RNA isolation and 
  Thus, this study demonstrates that Blimp-1 represses IL-2 
production after T cell activation and shows that the molecular 
mechanism responsible depends, at least in part, on Blimp-1  –
  dependent repression of   Il2   and   Fos   transcription. Further-
more, we identify Blimp-1 response elements in these two 
genes. The conclusion that Blimp-1 represses IL-2 transcrip-
tion is supported by several observations: (a) Blimp-1  –  express-
ing cells do not express IL-2 protein at detectable levels; (b) 
Blimp-1 mRNA induction correlates with IL-2 mRNA down-
regulation; (c) IL-2 protein and steady-state mRNA are ele-
vated in Blimp-1  –  defi  cient CD4  +   T cells; and (d) endogenous 
Blimp-1 specifi  cally binds to a regulatory region in the   Il2   gene 
in activated primary CD4  +   T cells. 
  This establishes Blimp-1 as an important component in a 
recently described IL-2 autoregulatory loop (  19  ) that oper-
ates in vivo to control the development and magnitude of 
T cell eff  ector responses, and it confi  rms and extends the sug-
gestion of Gong and Malek, that Blimp-1 plays an important 
role in IL-2 autoregulation (  12  ). 
  Interestingly, after activation in vitro, IL-2 production in 
Blimp-1  –  defi  cient T cells eventually decreases, although more 
slowly than in Blimp-1  –  suffi   cient cells (  Fig. 1 and Fig. 3 A  ). 
Thus, mechanisms in addition to Blimp-1 are apparently pre-
sent for IL-2 down-regulation. Nonetheless, Blimp-1 is im-
portant physiologically for IL-2 repression because lack of 
Blimp-1 results in increased IL-2 production upon antigen 
immunization in vivo. Increased levels of IL-2 produced by 
CKO cells are associated with increased proliferation both 
in vitro and in vivo (Fig. S1 and   Fig. 5  ), and with increased re-
sistance to cytokine deprivation-induced cell death after acti-
vation in vitro (  Fig. 2  ). Thus, deregulation of IL-2 production 
in the Blimp-1 CKO mice is likely to contribute to the aber-
rant T cell homeostasis and the infl  ammatory phenotype ob-
served in these mice. 
    MATERIALS AND METHODS   
  Mice.     C57BL/6 (B6) and B6 CD45.1 congenic mice were purchased from 
The Jackson Laboratory.   Prdm1    fl  ox/fl  ox   (  3  ) were backcrossed 10 times with 
B6 mice, and then crossed with B6CD4-Cre mice, which were purchased 
from Taconic, to generate B6   Prdm1    fl  ox/fl  ox  CD4-Cre  +   (Blimp-1CKO) and 
  Prdm1    +/+   CD4-Cre  +   (Control). For some in vitro experiments, mixed B6   ×   
129   Prdm1    fl  ox/fl  ox  Lck-Cre   Prdm1    +/+  Lck-Cre (  10  ) were also used. Mice bear-
ing a BAC transgene-encoding membrane-target EGFP (mEGFP) under the 
control of Blimp-1 regulatory elements (Blimp-1 EGFP) (  7  ) were a gift from 
M. Nussenzweig (The Rockefeller University, New York, NY) and were 
used as a reporter of Blimp-1 mRNA expression. In these mice, EGFP ex-
pression closely recapitulates Blimp-1 mRNA expression (  7  ). For some 
  experiments, spleen cells from Blimp-1 reporter mice were provided by 
S. Kaech’s laboratory (Yale University, New Haven, CT). All mice were 
maintained in a specifi  c pathogen  –  free animal facility at Columbia University 
and handled in accordance with the institutional guidelines. Animal experi-
ments were approved by the Institutional Animal Care and Use Committee 
at Columbia University. 
  Cell isolation, stimulation, and IL-2 production.     Naive CD4  +   (CD44  lo  ) 
cells were sorted using a FACSAria fl  uorescent cell sorter (BD Biosciences). 
Routinely, purity of all cell preparation was   >  90%. For Blimp-1 ChiP ex-
periments, naive CD4  +   T cells were purifi  ed by negative selection using 
FITC-labeled antibodies and      FITC magnetic beads. The negatively isolated JEM VOL. 205, September 1, 2008  1965
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cultured for 5 d. On day 5, cells were washed extensively in complete RPMI 
medium and replated at the same initial density in the presence (50 U/ml) or 
absence of rHuIL-2. The percentage of live cells (7-AAD        /Annexin V        ) 
was assessed 1, 2, or 3 d later. 
  Online supplemental material.     Fig. S1 shows that lack of Blimp-1 results 
in increased proliferation upon antigen-specifi  c stimulation in vitro. Table S1 
shows the putative Blimp-1 binding sites at the   Il2   gene. Table S2 lists the 
primers used for Blimp-1 ChIP at the   Il2   gene. The online version of this article 
is available at http://www.jem.org/cgi/content/full/jem.20080526/DC1. 
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